These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17964911)

  • 21. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.
    Nguyen NT; Magno CP; Lane KT; Hinojosa MW; Lane JS
    J Am Coll Surg; 2008 Dec; 207(6):928-34. PubMed ID: 19183541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological treatment and therapeutic perspectives of metabolic syndrome.
    Lim S; Eckel RH
    Rev Endocr Metab Disord; 2014 Dec; 15(4):329-41. PubMed ID: 25342235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome: are we at risk?
    Paudel B
    Nepal Med Coll J; 2007 Sep; 9(3):204-11. PubMed ID: 18092442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal treatments for the metabolic syndrome.
    Giugliano D; Esposito K
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):e30. PubMed ID: 16556857
    [No Abstract]   [Full Text] [Related]  

  • 25. The metabolic syndrome in hypertension: European society of hypertension position statement.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
    J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update.
    Selwyn AP
    Am J Cardiol; 2007 Dec; 100(12A):33P-37P. PubMed ID: 18154745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment modalities of obesity: what fits whom?
    Hainer V; Toplak H; Mitrakou A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of short-duration lifestyle intervention in collaboration with general practitioners in patients with the metabolic syndrome.
    Bihan H; Takbou K; Cohen R; Michault A; Boitou F; Reach G; Le Clésiau H
    Diabetes Metab; 2009 Jun; 35(3):185-91. PubMed ID: 19299181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of obesity and lifestyle interventions in the prevention and management of type 2 diabetes.
    Davis N; Forges B; Wylie-Rosett J
    Minerva Med; 2009 Jun; 100(3):221-8. PubMed ID: 19571786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome: an evolving concept.
    Cortez-Dias N; Martins S; Fiuza M
    Rev Port Cardiol; 2007 Dec; 26(12):1409-21. PubMed ID: 18338669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome.
    Opie LH
    Circulation; 2007 Jan; 115(3):e32-5. PubMed ID: 17242286
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of biofeedback in diabetes and essential hypertension.
    McGrady A
    Cleve Clin J Med; 2010 Jul; 77 Suppl 3():S68-71. PubMed ID: 20622080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
    St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
    J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriasis and the metabolic syndrome.
    Gottlieb AB; Dann F; Menter A
    J Drugs Dermatol; 2008 Jun; 7(6):563-72. PubMed ID: 18561588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic syndrome: definition, diagnosis and management.
    Novo S; Balbarini A; Belch JJ; Bonura F; Clement DL; Diamantopoulos E; Fareed J; Norgren L; Poredos P; Rotzocil K; ; ;
    Int Angiol; 2008 Jun; 27(3):220-31. PubMed ID: 18506125
    [No Abstract]   [Full Text] [Related]  

  • 36. Translating the Diabetes Prevention Program into an urban medically underserved community: a nonrandomized prospective intervention study.
    Seidel MC; Powell RO; Zgibor JC; Siminerio LM; Piatt GA
    Diabetes Care; 2008 Apr; 31(4):684-9. PubMed ID: 18252904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.
    Andreadis EA; Katsanou PM; Georgiopoulos DX; Tsourous GI; Yfanti GK; Gouveri ET; Diamantopoulos EJ
    Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):175-80. PubMed ID: 19053032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of lifestyle modification on central artery stiffness in metabolic syndrome subjects with pre-hypertension and/or pre-diabetes.
    Aizawa K; Shoemaker JK; Overend TJ; Petrella RJ
    Diabetes Res Clin Pract; 2009 Feb; 83(2):249-56. PubMed ID: 19097666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the metabolic syndrome in pediatrics: a blessing and a curse.
    Battista M; Murray RD; Daniels SR
    Semin Pediatr Surg; 2009 Aug; 18(3):136-43. PubMed ID: 19573755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health care utilization and costs by metabolic syndrome risk factors.
    Boudreau DM; Malone DC; Raebel MA; Fishman PA; Nichols GA; Feldstein AC; Boscoe AN; Ben-Joseph RH; Magid DJ; Okamoto LJ
    Metab Syndr Relat Disord; 2009 Aug; 7(4):305-14. PubMed ID: 19558267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.